CRSP

gimmebadvibes

CRSP with the vertical line pre market

gimmebadvibes

Looking like tomorrow gunna be another CRSP autumn day

krazay88

Bought CRSP and now it’s dipping

IceBearLikesToCook

Why are we bullish CRSP?

guploka

Already printing calls on CRSP 16 Jan 75$ and 80$ strike. And NTLA 16 Jan 25$ and 22.5$ 🚀

envelopyoursoul

Fly CRSP Fly

Crazy_Reporter_7516

CRSP $75 strike Im gonna lose it all

lomo_de_puerco

Donnie announces his intent [to direct the federal government] to buy $CRSP to facilitate his ambition to beat Xi and Puti Tang to immortality.

Lawlzie

someone posted about $CRSP yesterday and i got 1k of calls. now im sittin on 2k of calls. oh fuhhh.

Orion_MacGregor

CRSP looking good amirite?

XaroDuckSauce

take me to the promised land CRSP

stanktoni

Yup tide is rising on gene editing. CRSP, BEAM, VRTX for the win

Psychological_One_74

If you want to get into gene editing, then CRSP is the wrong way. It's old tech. No one does ex-vivo therapy since it's very expensive, far too invasive and not some thing you can mass produce to make profitable. $2M-$3M per patient, what insurance company is going to pay that. Requires flushing out all your bone marrow to work, far to invasive. Even CRSP knows this since they are now pivoting towards in-vivo which is non-invasive, can be mass produced, and can therefore can be commercialized. All CRSP wanted to do was get first to market but they are now so far behind with in-vivo. It's the reason why VERV got bought out and NTLA is pumping.

Mother-Chipmunk2778

Isn’t CRSP a huge piece of shit

Revfunky

Peter Lynch’s ten-bagger strategy comes to mind. If you put $100 and it grows 10x now you have $1k. If you can flip that to another ten-bagger now you are at $10k. Try to find 10 ten-baggers. Something like CRSP which has a lot of potential not based on any fundamentals or technicals and more the technology platform itself. You are essentially buying the dream-backed by Nobel-Prize winning science and validated by FDA approval.

Polishzebracamel

WSB doesnt let me post original posts. I wanted to post about NTLA at 9$ in May. CRSP is a great company, however NTLA is where the explosive growth is, in early 2026 it will be $40 solid. Insiders buying, positive trial news

Negative_Song_6362

mRNA and siRNA technology are different. One produces proteins, the other silences production of proteins. But to both of your points - it's about sentiment. The QURE news will likely pump both MRNA and CRSP because of industry progress and sentiment. That's why CRSP and MRNA hit 200 and 350 respectively in 2021 - sentiment positions: long CRSP since Feb

GoShogun

If you like CRSP, take a look at VRTX as well. Recently pummeled but they take 60% of the profit from CRSP's Casgevy treatment which has just started rolling out.

wattap

CRSP

killerbeeswaxkill

I like my options CRSP and worthless LFG

Doodl3s

You can argue they're both forms of gene therapy... however, Injecting an RNA via viral vector is MRNAs technology. Its exactly how the COVID shot worked. Actually cutting DNA and splicing the gene itself is Very different with much worse risks that have occurred which is why CRSP and EDIT got knocked for years after killing people. You may be right that CRSP will go up, and i also do believe in their potential, but your DD about QURE is irrelevant and actually applies to MRNA QURE was a huge deal, I'm actually ecstatic. QURE worked by injection of RNA via viral vector. For that reason, MRNA is what was validated by QURE, NOT CRSP. - science degree in some bullshit nobody cares about

ProfessionalSite1298

Cathie wood [Cathie’s new holdings](https://cathiesark.com/arkk-holdings-of-CRSP)

Doodl3s

CRSP has very little to do with QURE. QUREs technology it's RNA... you should buy MRNA, not CRSP

ai-moderator

#TLDR --- Ticker: CRSP Direction: Up Prognosis: Buy JAN '26 $80 Calls Catalyst: Massive 30% short interest, significant insider buys for the first time in years, and positive regulatory tailwinds for the gene therapy sector.

Visual-Listen353

Bruh forget the rest of this boomer bingo card, $CRSP is the real lottery ticket. We’re literally talking about editing human cheat codes at the DNA level while the rest of your portfolio is out here trying to sell socks on the internet. Yeah it’s volatile, yeah it bleeds faster than my brokerage account after FOMC minutes, but if they nail even one therapy it’s tendies for life. This is either “retire in Bali” or “working night shift at Wendy’s” money, and I’m here for it. Diamond hand the science, paper hand the rest. 🚀🧬

Mother-Chipmunk2778

Cathie wood been selling the shit out of ROKU and TEM and buying the shit out of CRSP and BLSH. But CRSP I’m pretty sure she’s bag holding so she just buys every dip to eventually break even

Then_Department_1347

$CRSP looking good and ready to pump!

Then_Department_1347

$CRSP looking good and ready to pump!

Then_Department_1347

$CRSP looking good and ready to pump!

Oplllia

CRSP

chatrep

CRSP is probably my riskiest one. I do like the space of gene editing but many others like BEAM and NTLA also doing well. They have good cash reserves and good progress. But 2 major factors for me… 1. While treating sickle cell is great, not much scale. But their phase 1 CTX310 is looking promising and focuses on cardiovascular health which is huge. I believe gene therapy is at infancy still and promising. 2. Recently a board director just bought a massive $50M mid-July. Some secondary factors… they have good cash runway, great brand recognition and this admin may be more favorable to medical trials and innovation. Could also be an acquisition target if trials progress. I don’t expect much day-to-day but don’t want to miss trial progress news or even acquisition.

featherbirdcalls

Wheel is great. Why $CRSP?

chatrep

Have no idea what qualifications HOOD used for summit. Not sure if it is balance or activity. I have a personal style if trading that works for me. Usually about 3-6 months. This past year, it was NVDA, then PLTR, then HOOD. Hard to summarize it all but basically when bullish, I look for best of the best. Then I set some milestones for exits. My next milestone for HOOD exit is 9/19 (maybe a few days after). I also shift my strategy based on risk. 1 wheel (low) 2. Leaps (mid) 3 shorter term ITM options (high). I am transitioning from 2 & 3 to low risk wheel. I will likely just hold CRSP, HOOD, ASTS, TSM and maybe RDDT (nervous about recent runup). Maybe even look into something like GDX as a hedge. I really like the income generation of wheeling sticks with some bit of volatility like above.

siahbabedblsiah

RKLB, SNAP, CRSP, and UPS about to go wild today for all the bears

D_Pablo67

Stocks: I would sell UNH and CRSP. The rest are excellent. Be ready to buy more of them on dips. ETFs: You have too many. Focus on QQQ and VOO. Fine to add JEPQ and JEPI if you want monthly income from covered call ETFs. Crypto: This will be the most volatile portion of your portfolio. I agree not to contribute more. Let it ride and trim a little on price surges. You are in great shape.

Harooooouuld

DYOR - don't just take a random person on the internet's advice. I haven't been buying as much in 2025 as I consider myself to be well positioned from purchases the last few years. But in 2025 I have averaged up on AMD, bought heavily into CRSP and adjecent companies, and as mentioned above, have been buying datacenter plays, such as CRWV, NBIS and IREN. I also bought the dip on TradeDesk. You can also see my history that I am looking for industries that won't experience a 75-90% drop in a bear market. For that reason, I stay away from space stocks, quantum computing stocks and SMR stocks. I will be interested in them when the next big crash comes along, for whomever is still around at that point.

Honest-Acanthisitta3

Hi all! Here’s my current portfolio with percent allocations: • NVDA: 20.6% • TSM: 9.7% • PLTR: 9.6% • AAPL: 8.9% • QQQ: 7.4% • VTI: 7.1% • MSFT: 6.9% • GOOGL: 6.8% • NUKZ: 5.9% • META: 5.7% • SOFI: 3.0% • TAN: 1.8% • BND: 1.8% • AMD: 1.4% • SCHD: 1.3% • AMZN: 1.0% • DRIV: 1.0% • JEPI: 0.9% • O: 0.2% • QTUM, ESPO, SPMO, UNH, CRSP: <1% each Notes: • I know this portfolio is very tech-heavy. • I contribute monthly to each position for dollar cost averaging, except for NVDA. I’ve paused monthly NVDA contributions to help balance its weight versus other holdings. • I don’t have as much time to monitor the market actively as I used to. • Should I consider consolidating or simplifying my portfolio for easier management? • I’m open to suggestions on better balance, or ideas for adding/removing stocks and ETFs. Thanks for your input!

Happy_Discussion_536

Bingo. And tbf, most of history is a few winners. Old comment of mine: Turns out stock-picking is very hard and cap-weighted works for a reason. Few winners hard carry everyone. >“The results also help to explain why active strategies, which tend to be poorly diversified, most often underperform,” says Bessembinder, who found that the largest returns come from very few stocks overall — **just 86 stocks have accounted for $16 trillion in wealth creation, half of the stock market total, over the past 90 years.** https://wpcarey.asu.edu/department-finance/faculty-research/do-stocks-outperform-treasury-bills Competition, new disruptive threats means companies go bust and lose often: >I calculate that the approximately 25,300 companies that issued stocks appearing in the CRSP common stock database since 1926 are collectively responsible for lifetime shareholder wealth creation of nearly $35 trillion, measured as of December 2016. However, just five firms (Exxon Mobile, Apple, Microsoft, General Electric, and International Business Machines) account for 10% of the total wealth creation. The 90 top-performing companies, **slightly more than one-third of 1% of the companies that have listed common stock, collectively account for over half of the wealth creation.** The 1,092 top- performing companies, slightly more than 4% of the total, account for all of the net wealth creation. That is, the remaining 96% of companies whose common stock has appeared in the CRSP data collectively generate lifetime dollar gains that matched gains on one-month Treasury bills. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2900447

DeepestWinterBlue

Haven’t seen CRSP named in a while

Legaon

Just go with (VT) or (VTI + VXUS) or (VTI + SPDW). These are all ETFs. —>VT = total world stock market. Tracks the “FTSE Global All Cap Index.” Invests in (emerging markets + developed markets). Invests in (small cap companies + mid cap companies + large cap companies). VT, or the index that it tracks — will automatically account for GLOBAL GEOPOLITICAL POLITICS. Aka: If the US were to “significantly lose its economic status,” (FTSE Global All Cap Index), VT will automatically, and overtim, (have a higher allocation to INTERNATIONAL COMPANIES) and (lower allocation to US COMPANIES). ->current allocation: (65% US equities + 35% international equities). ->US loses economic status allocation: (55% US equities + 45% international equities). ->You see the (re-balancing part)? This happens overtime, and automatically. No need to worry about (a single country experiencing hyperinflation/black swan event/etc). —>VTI = total US stock market. Tracks the “CRSP US Total Market Index.” Invests in 100% (US equities) or (US companies). Invests in (small cap companies + mid cap companies + large cap companies). VOO would just track only (large cap US companies). —>VXUS = total international stock market. Does not include US companies. (emerging markets + developed markets). —>SPDW = total international stock market. Does not include US companies. Only (developed markets). ->In my opinion, I would just go with (VT). Simple, and diversified. You do not have to worry so much about certain hypothetical scenarios. Rare events, but you never know what is going to happen in the future

shanerz96

CRSP, game changing healthcare technology to potentially cure genetic diseases

skitskat7

BEAM as the leader, and several others in contention (NTLA, PRME, CRBU, CRSP) in the gene editing space (specifically crispr and base editing).

redfour0

CRSP

pstbo

Most people don’t have patience for 5 years, but if you do: CRSP

liftrunbike

Agree on CRSP. Great potential and they’re having exciting trial results. I would love to hear your take on LUMN. I almost bought it earlier this month but didn’t. They’re up 18% since then and now I’m kicking myself.

123Nebraska

Agree on CRSP. And EDIT

TicketsToPluto

Should I yolo my 90 year old mothers savings into $CRSP $BEAM and $NTLA ?

Mother-Chipmunk2778

Sorry that and CRSP. Lmao. Your post history is crazy bro

jeromepain

Good lord bought some CRSP calls just for it to drop 5% in the last 10 fuckin minutes

Mother-Chipmunk2778

Man that pos stock I sold as soon as I broke even, fkn CRSP randomly dumps 5-10 percent in a day

wright_on_

oh look more $CRSP insider buying

Prudent-Corgi3793

As I mentioned in another comment, the benchmark uses the MSCI indices for each country, gross return (i.e. inclusive of dividends), denominated in USD. Specifically, it uses the investable market index (IMI), which also includes smaller companies. There isn't an ETF product directly linked to the MSCI USA IMI index, but this is basically completely correlated with the CRSP US Total Stock Market index, to which VTI is benchmarked. They basically [move together](https://i.imgur.com/JCuCF1c.png). There also aren't ideal country-specific ETF products to track the IMI. For instance, the [MSCI China IMI index](https://www.msci.com/indexes/index/664216) has 784 holdings, but Blackrock's MCHI tracks MSCI China, not the IMI, and only has 550 holdings. It also has an expense ratio of 0.59%, and similary across the board for all the country-specific ETFs. You do get a better comparison if you go with broad international ETFs, instead of country specific ones: - Blackrock's IDEV tracks the MSCI World ex USA IMI index for 0.04% (developed ex-US). - Blackrock's IEMG tracks the MSCI Emerging Markets IMI index for 0.07%. As you can see, there is some slight tracking error between the ETFs and the indices they track, but it has actually favored the ETFs so far this year (i.e. better for investors).

Happy_Discussion_536

I expect RSP to underperform SPY but it'll still be green. Just not as good as the monster money printers. And tbf, most of history is a few winners. Old comment of mine: Turns out stock-picking is not so easy that anybody can do it and most stocks are crap. >“The results also help to explain why active strategies, which tend to be poorly diversified, most often underperform,” says Bessembinder, who found that the largest returns come from very few stocks overall — **just 86 stocks have accounted for $16 trillion in wealth creation, half of the stock market total, over the past 90 years.** https://wpcarey.asu.edu/department-finance/faculty-research/do-stocks-outperform-treasury-bills Competition, new disruptive threats means companies go bust and lose often: >I calculate that the approximately 25,300 companies that issued stocks appearing in the CRSP common stock database since 1926 are collectively responsible for lifetime shareholder wealth creation of nearly $35 trillion, measured as of December 2016. However, just five firms (Exxon Mobile, Apple, Microsoft, General Electric, and International Business Machines) account for 10% of the total wealth creation. The 90 top-performing companies, **slightly more than one-third of 1% of the companies that have listed common stock, collectively account for over half of the wealth creation.** The 1,092 top- performing companies, slightly more than 4% of the total, account for all of the net wealth creation. That is, the remaining 96% of companies whose common stock has appeared in the CRSP data collectively generate lifetime dollar gains that matched gains on one-month Treasury bills. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2900447

Ok-Prior-9953

CRSP

Rav_3d

Revenge investing is a good way to lose more money. Not saying it's a bad idea to invest in stocks, but you'd be starting investments in SHOP, PLTR after huge earnings gaps, NVDA after it has doubled in 3 months with no pause, and CRSP which is probably just as risky as the biotech that destroyed your account. You lost thousands by not having a plan. So have one before you just randomly throw $200/week at stocks.

Happy_Discussion_536

Turns out stock-picking is not so easy that any retard can do it and most stocks are shit. >“The results also help to explain why active strategies, which tend to be poorly diversified, most often underperform,” says Bessembinder, who found that the largest returns come from very few stocks overall — **just 86 stocks have accounted for $16 trillion in wealth creation, half of the stock market total, over the past 90 years.** https://wpcarey.asu.edu/department-finance/faculty-research/do-stocks-outperform-treasury-bills Competition, new disruptive threats means companies go bust and lose often. And that's great for society. >I calculate that the approximately 25,300 companies that issued stocks appearing in the CRSP common stock database since 1926 are collectively responsible for lifetime shareholder wealth creation of nearly $35 trillion, measured as of December 2016. However, just five firms (Exxon Mobile, Apple, Microsoft, General Electric, and International Business Machines) account for 10% of the total wealth creation. The 90 top-performing companies, **slightly more than one-third of 1% of the companies that have listed common stock, collectively account for over half of the wealth creation.** The 1,092 top- performing companies, slightly more than 4% of the total, account for all of the net wealth creation. That is, the remaining 96% of companies whose common stock has appeared in the CRSP data collectively generate lifetime dollar gains that matched gains on one-month Treasury bills. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2900447

I_Own_A_Fedora_AMA

CRSP crash is a leading indicator, risk off is beginning

wright_on_

for real though why did that director drop $50M on CRSP

Abzu_Kukku

Look for calls on CRSP and AEVA instead.

Abzu_Kukku

Selling my OCT expiry CRSP puts somewhere between \~$51.50 and \~$47.

jeromepain

CRSP fuckin me today with a surprise earnings release. There goes my port ☹️

Thin_Cat8817

Since fucking when was CRSP reporting today??

Happy_Discussion_536

It's another r/collapse for retards like you. Go back in your hole. >Equal weight has been getting crushed and some people trade things other than SPY sir. It’s like 3 companies holding this together There's a reason why SPX is not equal weighted? Lmao. You act like this isn't 100% normal. Turns out stock-picking is not so easy that any retard can do it and most stocks are shit. >“The results also help to explain why active strategies, which tend to be poorly diversified, most often underperform,” says Bessembinder, who found that the largest returns come from very few stocks overall — **just 86 stocks have accounted for $16 trillion in wealth creation, half of the stock market total, over the past 90 years.** https://wpcarey.asu.edu/department-finance/faculty-research/do-stocks-outperform-treasury-bills Competition, new disruptive threats means companies go bust and lose often. And that's great for society. >I calculate that the approximately 25,300 companies that issued stocks appearing in the CRSP common stock database since 1926 are collectively responsible for lifetime shareholder wealth creation of nearly $35 trillion, measured as of December 2016. However, just five firms (Exxon Mobile, Apple, Microsoft, General Electric, and International Business Machines) account for 10% of the total wealth creation. The 90 top-performing companies, **slightly more than one-third of 1% of the companies that have listed common stock, collectively account for over half of the wealth creation.** The 1,092 top- performing companies, slightly more than 4% of the total, account for all of the net wealth creation. That is, the remaining 96% of companies whose common stock has appeared in the CRSP data collectively generate lifetime dollar gains that matched gains on one-month Treasury bills. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2900447

Apocalyptic-Post

CRSP - Casgevy sales updates at 4:30 via VRTX

Apocalyptic-Post

CRSP is gapping up right now Large volume orders after crossing $59 Think this could run back to $70+ this week

Apocalyptic-Post

CRSP running on the daily into expected earnings/updates…

Apocalyptic-Post

$CRSP could fly tonight with $VRTX providing CASGEVY results

Revfunky

You almost always miss the boat following the herd. For those of us married to the game we are dialed in to as much pertinent information as possible. If I don’t know the answer, I know someone that does know. If you miss it there is someone else to dance with. The answer to your question is yes there are more like Nvidia. You probably won’t see them on Reddit though. One of the beginning stages of investing is what should I buy? Eventually as you become more nuanced you find plenty of stocks you can buy. The question ceases to exist. Then it becomes about the money to be able to invest in those ideas. Some stocks I think have big potential for growth in that space. RXRX-CRSP-ARM are a couple in my AI portfolio. The strategy has no trailing stops and we are buying on the dips until 2030. CRSP is one of the rare situations where fundamentals aren’t a major consideration. We are investing in the potential of the technology. I still think this has the potential to be a ten-bagger and possibly mint some millionaires.

chatrep

Yup. Just added ITM leaps for CRSP, HOOD, ASTS, TOS. We’ll see how the next 6-12 months shapes up.

siahbabedblsiah

CRSP about to pop

siahbabedblsiah

CRSP about to pop

RoccoFb

!banbet CRSP -5% 1D

siahbabedblsiah

Get ready for CRSP to skyrocket this morning 🎉

BrilliantClarity

Are you buying any dips today? We could go down more but who knows? Picking up some CRSP ahead of next week earnings

tobygwa

Why are CRISPR stocks ($BEAM, $CRSP, $NTLA) so heavily shorted?

DrGamble6

Aug22 CRSP call. Just closing my eyes and pointing

Apocalyptic-Post

CRSP calls An insider literally bought $50 million worth of stock two weeks ago Earnings early next week, including VRTX update on Casgevy sales Generous dip yesterday was due to NVO and UNH dragging down the whole sector

Accord-ing_25_Tim

So I’ve used ChatGPT in a loosely similar manner, and the complexity of the prompt (plus deep level follow on conversation) is what really helps drill down to what you’re looking for. Based on a lengthy discussion about thesis, aggressiveness, convictions, etc, I asked it to recommend 10 stocks to round out exposure in key areas, and it recommended BLK, COIN, VRTX, REGN, NTLA, CRSP, SNOW, PDYN, SMR, and ARKW ETF. I made purchases of three of these and I’m up ~40% since.

Apocalyptic-Post

Went balls deep in CRSP calls for next week’s earnings

wright_on_

still thinking about the CRSP insider who bought $51M worth of shares lol

Apocalyptic-Post

I like CRSP calls here

Professional_Help_85

Cathie Woods offloads CRSP... now it will rise lol

UuuBetcha

I’m in $IBB and $CRSP

VortexLeon

CRSP

SANTAisGOD

CRSP

Cryatos1

Internationally based stocks. Im in on CRSP, N u holdings, and Rolls Royce. Trying to hedge against US BS lol.

pstbo

CRSP $50mil insider purchase, readouts coming, ER in 2 weeks

worknplay28

Long: RKLB NVDA TSLA CRSP Mid: Saving for above. Short: Think about saving for above.

pstbo

CRSP $50mil insider purchase, readouts coming, ER in 2 weeks

MADD-Scientis

That’s a great point RE: non-dilutive capital raise. I didn’t know they were exploring that. CRSP did the same thing- they gave Vertex 10% more of the casgevy profit share for $1B in cash

sagebarista500

CRSP is definitely better positioned regarding cash. Though last earning call Intellia’s CFO was pretty confident about capital position and pointed out that in 2-3 year timeframe also collaboration or some royalty arrangement could be subsitute/addition to the capital raise. Either way, I am quite confident on the future of both companies.

pstbo

Director of CRSP just dropped $50mil which has a $5B market cap. One of the largest insider purchases of any company. That’s twice the money for a company 2% the size of UNH. And CRSP is curing disease. UNH is denying disease. Fuck UNH.

PM_ME_OR_DONT_PM_ME

CRSP is a pretty easy swing trade, likes to pop up and down a lot, but rarely keeps dumping

EvanDDavidson

Looking like CRSP and the whole gene-editing space could be the next big thing.

whodowhodo

what even is up with CRSP

pstbo

I am holding it for the long term, although given the recent massive insider buy from SR One, the short term seems very enticing too. Wait out biotech until phase 3 success or approval and there will be no upside. By the time phase 3 starts, they are usually sufficiently de-risked. Phase 2 is where the most gains are usually made. As for semaglutide beating it to market and eating its lunch in CVD: No study has shown semaglutide reduces CVD risk in non-diabetics or people with normal BMI (not obese). And based on how it works, it wouldn’t reduce CVD risk in those populations anywhere near mainstay treatments. It would be complimentary to a subset of the patient population at best. The reason why it reduces CVD risk in diabetics and obese individuals is mainly because it treats diabetes and obesity, meaning diabetes and obesity themselves are risk factors for CVD. The genes CRSP’s CVD pipeline targets are among the most genetically validated targets in CVD. Lp(a) is high in 20% of the population, and is worse than LDL-C and there is not treatment for it on the market. Its gene is known, and it has been almost eliminated in studies and CRSP’s own trial. Same with ANGPTL3 for LDL and TG and AGT for hypertension. These are all proven endpoints for clinical trials in CVD. Noncompliance is a huge issues in medicine in general, especially CVD patient population. Semaglutide and the like are extremely overblown by the media and celebrity doctors. They’re not a magical drug. They’re just more obese people than lay people realized. What is CRSP is targeting is proven. The effect they will have on the risk of CVD is proven. That’s why they are validates clinical endpoints. Proven, in biology, means a lot. Not many others can claim that. Why? Because these genes are known based on loss of function mutations in humans to have these effects. So, in a sense, the clinical trial has already been done. What’s actually being tested is the toxicity and gene delivery modality. And the initial toxicity data that just came out looks great. And the gene editing platform, using crispr instead of prime editing or newer modalities like its competitors is a better strategy because it has a much longer track record, we know more about it, and the off target effects based on studies is so minimal that even if you used other modalities it wouldn’t make a difference and would come with much more significant trade offs.

pstbo

They have active trials, an approved therapy, and IMO best gene therapy platform. I have a medical background so I have some knowledge in this space. If there in vivo pipeline works, there will be a CURE for hypertension and high cholesterol. Basically eliminating all CVD risk. Noncompliance for CVD is very high. This is one and done. Also those a million other biotechs are usually 1 or 2 trials away from insolvency. CRSP has probably the best balance sheet of any.

moorhound

Dude I was waiting for CRSP to cure COVID. They're doing a lot of cool shit I'm too dumb to understand right now, call me back when they have something marketable, until then there's a million other biopharmas to gamble on with active trials

Fix_The_Money

CRSP is going to pop off when it can cure herpes

pstbo

JIM CRAMER just said CRSP “CAN TRIPLE FROM HERE OR STAY FLAT. GREAT SPECULATIVE STOCK”. With all the momentum behind it recently, take that as you will.